To Russia, With Love: Selecta, BIND To Create Subsidiaries In Financing Deals With Rusnano
This article was originally published in PharmAsia News
Executive Summary
Selecta Biosciences Inc. and BIND Biosciences Inc., two Boston-based -- and heretofore low-profile -- young biotechs, have raised a combined $94.5 million from a mix of equity financings and strategic alliances with one of the world's largest investment funds dedicated to nanotechnology, Rusnano, and other investors